Sarepta Therapeutics Announces Second Quarter 2017 Financial Results and Recent Corporate Developments
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Sarepta Therapeutics (SRPT) PT Raised to $33 at Morgan Stanley
July 20, 2017 9:16 AM EDTMorgan Stanley raised its price target on Sarepta Therapeutics (NASDAQ: SRPT) to $33.00 (from $31.00) while maintaining a Equalweight rating.
... MoreSarepta Therapeutics (SRPT) PT Raised to $69 at Cowen Following 'Beat and Raise'
July 20, 2017 6:07 AM EDTCowen analyst Ritu Baral raised its price target on Sarepta Therapeutics (NASDAQ: SRPT) to $69.00 (from $62.00) while maintaining a Outperform rating following a solid beat and raise for Exondys 51 revenues.
Baral sees continued progress with both prescribers and payors... More
